secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dyne Therapeutics, Inc. (DYN)
CIK:        0001818794
Form:       8-K
Filed at:   2024-11-12T23:59:59+00:00
Accession:  0001193125-24-255269
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Dyne upsizes ATM offering from $200M to $300M; $101.2M already sold
-------------------------------------------------------------------

- Filed prospectus supplement to sell up to $300M common stock via ATM with Jefferies, up from $200M.
- As of Nov 12, 2024, aggregate gross proceeds of ~$101.2M already sold under prior $200M program.
- New supplement replaces prior prospectus; no further sales will be made under the old one.
- Shares registered under existing shelf registration statement; legal opinion included as exhibit.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1818794/000119312524255269/0001193125-24-255269-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1818794/000119312524255269/d867502d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-255269

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer